Navigation Links
Europe spends nearly twice as much as US on nanotech risk research

Washington, DC A new analysis by the Project on Emerging Nanotechnologies (PEN) indicates that European nations are investing nearly twice as much as the U.S. in research primarily aimed at addressing the potential risks of nanotechnology. The analysis also highlights a substantial over-inflation of the federal governments nanotechnology risk-research investment figures for the U.S.

The new PEN assessment of nanotechnology risk-relevant projects identified by the federal governments National Nanotechnology Initiative (NNI) for fiscal year 2006 found that only $13 million was invested in projects highly relevant to addressing possible risks.

Over the same time period, the PEN analysis found European countries invested nearly $24 million in projects with the primary aim of addressing nanotechnology risks.

PEN evaluated research projects listed in the NNI research strategyreleased in February 2008 but without specifics regarding the annual project budget or the applicability of each project to assessing potential hazardsby their relevance to addressing current and future nanotechnology risks. Research was classified according to whether it was highly relevant to addressing potential environment, health or safety hazards, substantially relevant, having some relevance, or was only marginally relevant.

By collecting individual project budget data from publicly available sources, an estimate was made of funding levels for 2006. The assessment found 62 federally-funded projects that were highly relevant to understanding nanotechnology risk, with an estimated annual budget of $13 million.

In contrast, the federal government estimates $37.7 million was invested in highly relevant research in fiscal year 2006. According to PEN Chief Science Advisor Andrew Maynard, It appears the U.S. is guilty of wishful thinking in its assessment of research that will lead to the development of safe nanotechnologies. It is trying to substitute research that might inform sciences general understanding of possible nanotechnology risks for research that is focused on getting answers to direct questions being asked todaywhat makes a nanomaterial potentially harmful, how can it be used safely, and what happens when it is eventually disposed" Both the U.S. government figure and the results of the PEN assessment show that less than 3 percent of the $1.4 billion federal nanotechnology research budget was spent on environment, health and safety research.

Draft legislation proposed by U.S. House of Representatives Science Committee Chair Bart Gordon (D-TN) would amend the NNI act to include a minimum 10 percent mandate for the nanotechnology federal research and development budget devoted to EHS research in the future, amounting to approximately $150 million annually.


Contact: Julia Moore
Project on Emerging Nanotechnologies

Related biology technology :

1. DuoCort Hosts Adrenal Insufficiency Symposium at the 10th European Congress of Endocrinology in Berlin
2. Squire Sanders Stands Out in Independent Analysis of Law Firms in Europe
3. High-Definition Technology to Revolutionize US & European Visualization Device Markets
4. Arbios Commences Process to Seek European Marketing Approval for SEPET(TM)
5. Cephalon Announces European Commission Approval of EFFENTORA for the Treatment of Breakthrough Cancer Pain
6. Intellect Neurosciences, Inc. Receives Notice of Allowance and Completes Grant Requirements for Pivotal European Patent Related to Passive Immunization of Alzheimers Disease
7. MaxCyte to Present at BIO-Europe Spring 2008 Conference
8. Cardiums InnerCool Therapies Unit Announces European Commercialization Agreement for Portfolio of Temperature Modulation Systems
9. Tengion Announces European Orphan Drug Designation for Neo-Bladder Augment
10. Volcano Announces U.S. and European Launch of Rotational IVUS and Integrated FFR
11. Campbell Alliance Sales Practice to Conduct Workshop at EyeForPharma SFE Europe Conference
Post Your Comments:
(Date:10/11/2017)... Wayne. NJ (PRWEB) , ... October 11, 2017 , ... Personal eye wash is a ... rinse one eye at a time. So which eye do you rinse first if a ... you have Plum Duo Eye Wash with its unique dual eye piece. , ...
(Date:10/11/2017)... the Netherlands and LAGUNA HILLS, Calif. ... The Institute of Cancer Research, London ... use MMprofilerâ„¢ with SKY92, SkylineDx,s prognostic tool to risk-stratify patients ... trial known as MUK nine . The University of ... trial, which is partly funded by Myeloma UK, and ICR ...
(Date:10/10/2017)... CALIF. (PRWEB) , ... October 10, 2017 , ... San ... part of its corporate rebranding initiative announced today. The bold new look is ... reach, as the company moves into a significant growth period. , It will also ...
(Date:10/10/2017)... International research firm Parks Associates announced today that ... TMA 2017 Annual Meeting , October 11 in Scottsdale, ... security market and how smart safety and security products impact the competitive ... Parks Associates: Smart Home Devices: Main ... "The residential security market has experienced continued ...
Breaking Biology Technology:
(Date:4/13/2017)... SANTA MONICA, Calif. , April 13, 2017 /PRNewswire/ ... New York will feature emerging and ... Innovation Summits. Both Innovation Summits will run alongside the ... variety of speaker sessions, panels and demonstrations focused on ... east coast,s largest advanced design and manufacturing event will ...
(Date:4/11/2017)... , April 11, 2017 NXT-ID, Inc. ... technology company, announces the appointment of independent Directors Mr. ... to its Board of Directors, furthering the company,s corporate governance ... Gino ... we look forward to their guidance and benefiting from their ...
(Date:4/4/2017)... YORK , April 4, 2017   EyeLock ... today announced that the United States Patent and Trademark ... patent broadly covers the linking of an iris image ... same transaction) and represents the company,s 45 th ... latest patent is very timely given the multi-modal biometric ...
Breaking Biology News(10 mins):